Updated:
Jiangsu Life Science & Technology Innovation Park
Jiangsu Life Science & Technology Innovation Park was established in 2009 through a joint mandate between the Qixia District Government and the Xianlin...
Jiangsu Life Science & Technology Innovation Park
Jiangsu Life Science & Technology Innovation Park was established in 2009 through a joint mandate between the Qixia District Government and the Xianlin University City Management Committee. It was created to convert academic research into commercial biotechnology and life-science enterprises, anchored physically around Nanjing University's School of Life Sciences. The park functions less as a passive landlord and more as an active industrial investor and developer, combining technology park operations with enterprise management planning and property management services. Its founding structure ties it directly to municipal planning objectives in Jiangsu Province. Investment activity concentrates on early-stage life-science translation and biopharmaceutical innovation. The park deploys capital through direct incubation programs, real-asset development of specialized laboratory and commercial space, and strategic co-location partnerships. Confirmed anchor collaborations include a formal relationship with AstraZeneca focused on biopharmaceutical innovation and treatment development within the Jiangsu region, and a technology-transfer partnership with Nanjing University's School of Life Sciences. Physical assets under management include the Nanjing Life Science Innovation Park A1 and A2 mixed-use projects, the F6 and F7 incubator buildings at 9 Weidi Road, and the Nanjing Lukou Airport City Culture Complex. Investment geography is concentrated in Nanjing, specifically Qixia District. The park's scale is measured in physical footprint rather than disclosed assets under management. Built assets span industrial, commercial, and mixed-use space anchored on Weidi Road. Governance flows through an Administration Committee led by Director Rong Yu, with dual oversight from the Qixia District Government and the Xianlin University City Management Committee. No team-size figures or total deployment numbers are publicly released. No adjacent philanthropic foundation, family-wealth origin, or club-membership structures have been disclosed. The park's distinguishing architecture is its hybrid identity as a government–university joint venture that simultaneously develops real estate and invests in tenant companies. Unlike a typical venture capital fund or science park operator, it controls both the physical incubation environment and the capital allocation pipeline, with an explicit mandate to align outcomes with the industrial policy goals of Qixia District and Jiangsu Province. This makes it an unusual allocator: a corporate investor structured as a municipal asset owner that evaluates returns through both financial and regional economic-development lenses.
General information
Firm type
Corporate Investor
Year founded
2009
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Nanjing
Corporate office
9 Weidi Road, Qixia District, Nanjing, Jiangsu, China
Principals
Rong Yu
Administration Committee Director
Sector focus
Frequently asked questions
Who runs investment and development decisions at Jiangsu Life Science & Technology Innovation Park?
The park is governed by an Administration Committee whose director is Rong Yu. The committee operates under the joint oversight of the Qixia District Government and the Xianlin University City Management Committee, which together established the park in 2009. No additional investment committee members or deal-team leaders have been publicly named.
How is the park related to Nanjing University?
Nanjing University is a formal business partner and anchor intellectual-property source. The collaboration operates primarily through the university's School of Life Sciences, which provides technology-transfer pathways and research partnerships that feed into the park's incubation pipeline.
Does the park operate as a venture investor or a real-estate developer?
It does both. The park makes direct industrial investments in life-science ventures — AstraZeneca is a named biopharmaceutical collaboration partner — and develops specialized real estate including incubator buildings, mixed-use innovation parks, and commercial facilities. The balance sheet combines operating property and equity interests in tenant and partner companies.
What are the park's principal physical assets?
Disclosed holdings include the Nanjing Life Science Innovation Park A1 and A2 mixed-use projects, the F6 and F7 incubator buildings at 9 Weidi Road in Qixia District, and the Nanjing Lukou Airport City Culture Complex. All are in Nanjing, Jiangsu Province, China.
What is the park's relationship with AstraZeneca?
AstraZeneca is a named business partner with which the park collaborates on biopharmaceutical innovation and treatment development in the Jiangsu region. The precise structure — whether co-investment, joint development, or a tenancy agreement — has not been publicly detailed.
Is Jiangsu Life Science & Technology Innovation Park a family office or privately controlled entity?
No. It is a state-linked corporate investor founded jointly by the Qixia District Government and the Xianlin University City Management Committee in 2009. There is no private family wealth origin. Its mandate is shaped by municipal industrial policy and regional economic development goals.
Does the park disclose its assets under management or deployment numbers?
No public AUM, total capital deployment, or portfolio market-value figures are disclosed. The park measures its scale through physical square footage and operational partnerships rather than through third-party audited asset totals.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: